Publication: 4274

Publication: 4274

Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 24 (16_suppl) TPS4205

Meeting Instance:: ASCO 2024
Year:: 2024
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Erica S. Tsang Qian Shi Ken Olive Eric Collisson Jesse Dixon Mike Cusnir Ardaman Shergill Jeffrey Meyerhardt Eileen O'Reilly Andrew H. Ko

Networks:: CA824, COLUMBIA, LAPS-IL057, LAPS-MA036, LAPS-NY016

Study: Alliance-A022106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: